First FDA-approved in July 2017 for plaque psoriasis, the list price for a 30-day supply of Tremfya was stated to be $6,292, according to the manufacturer
As of 2026, both Retatrutide and Survodutide are in advanced stages of clinical research, demonstrating highly promising results for metabolic health
The body adapts to the delayed gastric emptying
Both Ozempic and Rybelsus have been demonstrated to induce weight reduction in individuals diagnosed with type 2 diabetes
Lotte Bjerre Knudsen (36:00): That's also just mentioned Richard DiMarchi, who I shared the Breakthrough Prize with, and also Svetlana Mojsov, who I was one of the other two recipients for the Lasker prize because they both been at Rockefeller, and they both have worked a lot with peptides, and they both say the same thing